Fortrea Holdings, Inc. (FTRE)
20.00
+0.60
(+3.09%)
USD |
NASDAQ |
Oct 02, 16:00
20.00
0.00 (0.00%)
After-Hours: 20:00
Fortrea Holdings Gross Profit Margin (Quarterly) : 17.63% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 17.63% |
| March 31, 2026 | 16.31% |
| December 31, 2025 | 16.93% |
| September 30, 2025 | 14.70% |
| June 30, 2025 | 16.04% |
| March 31, 2025 | 14.89% |
| December 31, 2024 | 17.23% |
| September 30, 2024 | 18.83% |
| June 30, 2024 | 17.47% |
| Date | Value |
|---|---|
| March 31, 2024 | 12.99% |
| December 31, 2023 | 15.44% |
| September 30, 2023 | 17.82% |
| June 30, 2023 | 18.34% |
| March 31, 2023 | 18.95% |
| December 31, 2022 | 18.24% |
| September 30, 2022 | 19.00% |
| June 30, 2022 | 19.59% |
| March 31, 2022 | 15.06% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Charles River Laboratories International, Inc. | 36.29% |
| IQVIA Holdings, Inc. | 26.20% |
| Medpace Holdings, Inc. | 27.56% |
| Champions Oncology, Inc. | 48.48% |
| Avantor, Inc. | 31.73% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -15.30% |
| Return on Assets | -3.11% |
| Return on Invested Capital | -4.97% |
| Profit Margin (Quarterly) | -1.95% |
| Operating Margin (Quarterly) | 2.58% |
| Return on Net Operating Assets | -3.50% |